Maternal inflammation during pregnancy and childhood adiposity

Obesity

Volumn 24, Issue 6, 2016, Pages 1320-1327

  Gaillard, Romy ^a   Rifas Shiman, Sheryl L ^b   Perng, Wei ^c   Oken, Emily ^b,d   Gillman, Matthew W ^b,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CHILDHOOD OBESITY; COHORT ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT FREE MASS; FAT MASS; FEMALE; GESTATIONAL AGE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFANT; INFLAMMATION; LARGE FOR GESTATIONAL AGE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; SOCIAL STATUS; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 84990201272     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21484     Document Type: Article

References (40)

1. Drake AJ, Reynolds RM. Impact of maternal obesity on offspring obesity and cardiometabolic disease risk. Reproduction 2010;140:387–398.
2. Denison FC, Roberts KA, Barr SM, Norman JE. Obesity, pregnancy, inflammation, and vascular function. Reproduction 2010;140:373–385.
3. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131–2135.
4. Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002;288:2008–2014.
5. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231–4237.
6. Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol 2007;29:151–162.
7. Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008;29:274–281.
8. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003;52:2951–2958.
9. Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007;92:969–975.
10. Sen S, Simmons RA. Maternal antioxidant supplementation prevents adiposity in the offspring of Western diet-fed rats. Diabetes 2010;59:3058–3065.
11. Dahlgren J, Nilsson C, Jennische E, et al. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab 2001;281:E326–E334.
12. Radaelli T, Uvena-Celebrezze J, Minium J, Huston-Presley L, Catalano P, Hauguel-de Mouzon S. Maternal interleukin-6: marker of fetal growth and adiposity. J Soc Gynecol Investig 2006;13:53–57.
13. Danielsen I, Granstrom C, Rytter D, et al. Subclinical inflammation during third trimester of pregnancy was not associated with markers of the metabolic syndrome in young adult offspring. Obesity (Silver Spring) 2014;22:1351–8.
14. Yeh ET. CRP as a mediator of disease. Circulation 2004;109:II11–II14.
15. Gillman MW, Rich-Edwards JW, Rifas-Shiman SL, Lieberman ES, Kleinman KP, Lipshultz SE. Maternal age and other predictors of newborn blood pressure. J Pediatr 2004;144:240–245.
16. Oken E, Baccarelli AA, Gold DR, et al. Cohort Profile: Project Viva. Int J Epidemiol 2015;44:37–48.
17. World Medical Association I. Declaration of Helsinki. Ethical principles for medical research involving human subjects. J Indian Med Assoc 2009;107:403–405.
18. Rich-Edwards JW, Mohllajee AP, Kleinman K, et al. Elevated midpregnancy corticotropin-releasing hormone is associated with prenatal, but not postpartum, maternal depression. J Clin Endocrinol Metab 2008;93:1946–1951.
19. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005;162:1108–1113.
20. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat Ser 11, Data Natl Health Surv 2002;1–190.
21. Boeke CE, Oken E, Kleinman KP, Rifas-Shiman SL, Taveras EM, Gillman MW. Correlations among adiposity measures in school-aged children. BMC Pediatr 2013;13:99
22. Wells JC. A critique of the expression of paediatric body composition data. Arch Dis Child 2001;85:67–72.
23. Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6
24. Oken E, Ning Y, Rifas-Shiman SL, Rich-Edwards JW, Olsen SF, Gillman MW. Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann Epidemiol 2007;17:663–668.
25. Regnault N, Gillman MW, Rifas-Shiman SL, Eggleston E, Oken E. Sex-specific associations of gestational glucose tolerance with childhood body composition. Diabetes Care 2013;36:3045–3053.
26. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4–12.
27. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–1143.
28. Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab 2012;38:183–191.
29. Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310–1320.
30. Timpson NJ, Nordestgaard BG, Harbord RM, et al. C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 2011;35:300–308.
31. Madan JC, Davis JM, Craig WY, et al. Maternal obesity and markers of inflammation in pregnancy. Cytokine 2009;47:61–64.
32. Friis CM, Paasche Roland MC, Godang K, et al. Adiposity-related inflammation: effects of pregnancy. Obesity (Silver Spring) 2013;21:E124–E130.
33. Ernst GD, de Jonge LL, Hofman A, et al. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study. Am J Obstet Gynecol 2011;205:132 e131–112.
34. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61–73.
35. Farah N, Hogan AE, O'Connor N, Kennelly MM, O'Shea D, Turner MJ. Correlation between maternal inflammatory markers and fetomaternal adiposity. Cytokine 2012;60:96–99.
36. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009;114:1326–1331.
37. Roberts KA, Riley SC, Reynolds RM, et al. Placental structure and inflammation in pregnancies associated with obesity. Placenta 2011;32:247–254.
38. Saben J, Lindsey F, Zhong Y, et al. Maternal obesity is associated with a lipotoxic placental environment. Placenta 2014;35:171–177.
39. Zhu MJ, Du M, Nathanielsz PW, Ford SP. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010;31:387–391.
40. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003;88:3507–3512.